GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (NAS:INDV) » Definitions » Purchase Of Business

INDV (Indivior) Purchase Of Business : $0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Indivior Purchase Of Business?

Indivior's purchase of business for the three months ended in Sep. 2024 was $0 Mil. It means Indivior spent $0 Mil on purchasing business. Indivior's purchase of business for the trailing twelve months (TTM) ended in Sep. 2024 was $0 Mil.

Compared with last quarter ($0 Mil in Jun. 2024 ), Indivior spent the same money on purchasing business in Sep. 2024 ($0 Mil).

Indivior Purchase Of Business Historical Data

The historical data trend for Indivior's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indivior Purchase Of Business Chart

Indivior Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -5.00

Indivior Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Indivior Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indivior Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Indivior's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Indivior Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (NAS:INDV) » Definitions » Purchase Of Business
Comparable Companies
LSE:HCM LSE:BMK LSE:APH LSE:HIK LSE:ANCR LSE:EAH LSE:AGY LSE:CEL LSE:STX LSE:VLG ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
INDVl:UK INDV:UK 2IVB:Germany
Address
10710 Midlothian Turnpike, Suite 125, North Chesterfield, Richmond, VA, USA, 23235
Website
https://www.indivior.com
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.